Tumor-targeted delivery of photothermal agent and controlled release of concomitant chemotherapeutic drug are two key factors for combined photothermal chemotherapy. Herein, we developed a ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

Hydrogels could revolutionize cancer treatment by facilitating targeted drug delivery, reducing adverse effects, and ...

The last time it was announced that Mary Beckerle would be leaving the Huntsman Cancer Institute, there was uproar. But this ...

A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about ...

In a bid to better understand how cancer cells power their explosive growth and spread, scientists at Johns Hopkins Medicine say they have shed new light on the location and function of ...

As federal funding changes hit universities, key research initiatives are scrambling to find cash. The Schroeder Lab at UA is ...

The province of Bataan in the Philippines is stepping up its cancer care services through a growing partnership with Sweden, ...

Risk factors for prostate cancer Risk factors for prostate cancer include: Gender. Only men are at risk. Age. Men ages 50 and older are at higher risk. Most prostate cancers are found in men older ...

Undergraduates from 14 schools across the country had the opportunity to explore the field of cancer research at a UAMS ...

Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

The pH (low) insertion peptides (pHLIPs) target acidity at the surfaces of cancer cells and show utility in a wide range of applications, including tumor imaging and intracellular delivery of ...